Cape Fear BioCapital
Overview
Cape Fear BioCapital is a venture capital firm focused on making seed stage investments in life sciences therapeutic companies located in North Carolina.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Incyclix Bio | Apr 2026 | Series B Extension | Co-investor |
| iOrganBio | Oct 2025 | Seed | Co-investor |
| Ten63 Therapeutics | Feb 2026 | Strategic | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cape Fear BioCapital based?
Cape Fear BioCapital is headquartered in Durham, North Carolina, United States.
When was Cape Fear BioCapital founded?
Cape Fear BioCapital was founded in 2024.
How many portfolio companies does Cape Fear BioCapital have?
Cape Fear BioCapital has 3 portfolio companies in Caplight's dataset.
What are some companies in Cape Fear BioCapital's portfolio?
Portfolio companies visible on Caplight include Incyclix Bio, iOrganBio, Ten63 Therapeutics.
What was Cape Fear BioCapital's most recent investment shown here?
Cape Fear BioCapital's most recent investment in this portfolio sample was in Incyclix Bio in 2026.
What sectors does Cape Fear BioCapital focus on?
Cape Fear BioCapital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, AI, Data & Cloud Infrastructure.
What company stages does Cape Fear BioCapital focus on?
Stage focus information for Cape Fear BioCapital is not publicly available.
What is Cape Fear BioCapital's AUM?
Cape Fear BioCapital's assets under management are estimated between $7.5M and $7.5M.